6618 CEO

Lijun  Xin

6618 Exec. Director

Exec. Director

6618 Core

刘强东

JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health and wellness products through direct selling and online retail pharmacy network. The company also provides online healthcare services, such as online consultation, prescription renewal, chronic disease management, family doctor, and consumer healthcare services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, its platform allows users to book appointments and pay for services, such as general physical exams, aesthetic medicines, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

JD Health received $1.35 billion in cornerstone round investment

JD Health completed $830 million in round B financing

JD.com established JD Health Sub-group, and round A raised more than 1 billion US dollars

京东健康获得13.5亿美元基石轮投资

京东成立京东健康子集团，A 轮融资超10亿美元